Company profile
OrganoTherapeutics
Using Midbrain Organoids for the development of new Therapeutics against Parkinson`s Disease.
- Industry
- Biotechnology Research
- Employees
- 10
- Headquarters
- Esch-sur-Alzette, Luxemburg
- LinkedIn followers
- 4,455
- Office locations
- 1
OrganoTherapeutics company summary
OrganoTherapeutics is a company in the Biotechnology Research industry, headquartered in Esch-sur-Alzette, Luxemburg. On LinkedIn the company has around 10 employees and 4,455 followers.
What technology does OrganoTherapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About OrganoTherapeutics
OrganoTherapeutics uses cutting-edge human-specific midbrain organoids for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary organoids which mimic faithfully the human Parkinson’s disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson’s disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.
Where is OrganoTherapeutics located?
OrganoTherapeutics lists 1 location.
Compare companies similar to OrganoTherapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
OrganoTherapeutics organo-therapeutics.com | Biotechnology Research | 10 | - | Esch-sur-Alzette, Luxemburg |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about OrganoTherapeutics
What does OrganoTherapeutics do?
OrganoTherapeutics uses cutting-edge human-specific midbrain organoids for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary organoids which mimic faithfully the human Parkinson’s disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson’s disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.
How many employees does OrganoTherapeutics have?
OrganoTherapeutics has around 10 employees on LinkedIn.
Where is OrganoTherapeutics headquartered?
OrganoTherapeutics is headquartered in Esch-sur-Alzette, Luxemburg.
Build a lead list from companies like OrganoTherapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.